Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis.
Delyon J, Brunet-Possenti F, Leonard-Louis S, Arangalage D, Baudet M, Baroudjian B, Lebbe C, Hervier B; PATIO Group. Delyon J, et al. Among authors: baroudjian b. Ann Rheum Dis. 2019 Nov;78(11):e129. doi: 10.1136/annrheumdis-2018-214336. Epub 2018 Sep 21. Ann Rheum Dis. 2019. PMID: 30242031 No abstract available.
Reply to 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance' by Funck-Brentano et al.
Goldwirt L, Chami I, Feugeas JP, Pages C, Brunet-Possenti F, Allayous C, Baroudjian B, Madelaine I, Sauvageon H, Mourah S, Lebbé C. Goldwirt L, et al. Among authors: baroudjian b. Ann Oncol. 2016 Feb;27(2):363-4. doi: 10.1093/annonc/mdv538. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578723 Free article. No abstract available.
[Melanoma, from diagnosis to treatment].
Baroudjian B, Pagès C, Lebbé C. Baroudjian B, et al. Rev Infirm. 2016 Mar;(219):16-8. doi: 10.1016/j.revinf.2015.12.022. Rev Infirm. 2016. PMID: 26944639 Review. French.
Anti-PD1-induced collagenous colitis in a melanoma patient.
Baroudjian B, Lourenco N, Pagès C, Chami I, Maillet M, Bertheau P, Bagot M, Gornet JM, Lebbé C, Allez M. Baroudjian B, et al. Melanoma Res. 2016 Jun;26(3):308-11. doi: 10.1097/CMR.0000000000000252. Melanoma Res. 2016. PMID: 26990271
Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.
Felix J, Cassinat B, Porcher R, Schlageter MH, Maubec E, Pages C, Baroudjian B, Homyrda L, Boukouaci W, Tamouza R, Bagot M, Caignard A, Toubert A, Lebbé C, Moins-Teisserenc H. Felix J, et al. Among authors: baroudjian b. Int Immunopharmacol. 2016 Nov;40:466-473. doi: 10.1016/j.intimp.2016.09.030. Epub 2016 Oct 8. Int Immunopharmacol. 2016. PMID: 27728898
88 results